Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial. Kamm CP, El-Koussy M, Humpert S, Findling O, Burren Y, Schwegler G, Donati F, Müller M, Müller F, Slotboom J, et al. PLoS One. 2014 Jan 3; 9(1):e86663. Epub 2014 Jan 30. PMID: 24497963. Abstract CommentRecommendBookmarkWatch